BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9108462)

  • 1. Detection of peroxisome proliferators using a reporter construct derived from the rat acyl-CoA oxidase promoter in the rat liver cell line H-4-II-E.
    Lee MJ; Gee P; Beard SE
    Cancer Res; 1997 Apr; 57(8):1575-9. PubMed ID: 9108462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene.
    Varanasi U; Chu R; Huang Q; Castellon R; Yeldandi AV; Reddy JK
    J Biol Chem; 1996 Jan; 271(4):2147-55. PubMed ID: 8567672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
    Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
    Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.
    Goll V; Alexandre E; Viollon-Abadie C; Nicod L; Jaeck D; Richert L
    Toxicol Appl Pharmacol; 1999 Oct; 160(1):21-32. PubMed ID: 10502499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes.
    Ammerschlaeger M; Beigel J; Klein KU; Mueller SO
    Toxicol Sci; 2004 Apr; 78(2):229-40. PubMed ID: 14976357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
    Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
    Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
    Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
    Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis.
    Yeldandi AV; Rao MS; Reddy JK
    Mutat Res; 2000 Mar; 448(2):159-77. PubMed ID: 10725470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferation as a biomarker in environmental pollution assessment.
    Cajaraville MP; Cancio I; Ibabe A; Orbea A
    Microsc Res Tech; 2003 Jun; 61(2):191-202. PubMed ID: 12740826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo.
    Bojes HK; Thurman RG
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):233-9. PubMed ID: 8209376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferators: a model for receptor mediated carcinogenesis.
    Green S
    Cancer Surv; 1992; 14():221-32. PubMed ID: 1330305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular toxicology of peroxisome proliferators.
    McNae F; Sharma R; Gibson GG
    Eur J Drug Metab Pharmacokinet; 1994; 19(3):219-23. PubMed ID: 7867664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of epithelial cells stably transfected with H2O2-generating peroxisomal urate oxidase.
    Chu R; Lin Y; Reddy KC; Pan J; Rao MS; Reddy JK; Yeldandi AV
    Cancer Res; 1996 Nov; 56(21):4846-52. PubMed ID: 8895731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?
    Melnick RL
    Environ Health Perspect; 2001 May; 109(5):437-42. PubMed ID: 11401753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proliferation of peroxisomes and the hepatocarcinogenic process].
    Palut D
    Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome enzyme modification and oxidative stress in rat by hypolipidemic and antiinflammatory drugs.
    Rivero A; Monreal JI; Gil MJ
    Rev Esp Fisiol; 1994 Dec; 50(4):259-68. PubMed ID: 7754169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiles in rat liver slices exposed to hepatocarcinogenic enzyme inducers, peroxisome proliferators, and 17alpha-ethinylestradiol.
    Werle-Schneider G; Wölfelschneider A; von Brevern MC; Scheel J; Storck T; Müller D; Glöckner R; Bartsch H; Bartelmann M
    Int J Toxicol; 2006; 25(5):379-95. PubMed ID: 16940010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
    Perrone CE; Shao L; Williams GM
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptors: finding the orphan a home.
    Green S; Wahli W
    Mol Cell Endocrinol; 1994 Apr; 100(1-2):149-53. PubMed ID: 8056148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An upstream region of the enoyl-coenzyme A hydratase/3-hydroxyacyl-coenzyme A dehydrogenase gene directs luciferase expression in liver in response to peroxisome proliferators in transgenic mice.
    Alvares K; Fan C; Dadras SS; Yeldandi AV; Rachubinski RA; Capone JP; Subramani S; Iannaccone PM; Rao MS; Reddy JK
    Cancer Res; 1994 May; 54(9):2303-6. PubMed ID: 8162569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.